|
시장보고서
상품코드
2126231
수의용 POC(Point of Care) 진단 시장(2026-2030년)Global Veterinary Point-Of-Care Diagnostics Market 2026-2030 |
||||||
세계의 수의용 POC(Point of Care) 진단 시장은 2025년부터 2030년까지 22억 5,580만 달러 증가하고, 예측 기간 동안 CAGR은 10.9%에 달할 것으로 예측됩니다.
본 보고서는 전 세계 수의용 POC(Point of Care) 진단 시장에 대한 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체를 대상으로 한 벤더 분석을 제공합니다.
본 보고서는 현재의 시장 상황, 최신 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장을 견인하고 있는 요인은 반려동물의 ‘인간화’ 경향이 강화되고 있다는 점, 북미 및 아시아태평양(APAC)에서의 도입률 상승, 인수공통감염병의 확산과 신속한 질병 감시의 필요성, 분자진단 기술의 발전 및 장비의 소형화입니다.
본 조사는 업계 주요 관계자들의 의견을 포함한 1차 정보와 2차 정보를 객관적으로 결합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석이 포함된 부문별 데이터, 그리고 벤더 현황이 수록되어 있습니다. 또한, 시장 규모 실적 및 향후 예측 데이터도 게재되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2030년 |
| 조사 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 2026년 전년 대비 | 10.2% |
| CAGR | 10.9% |
| 증가액 | 22억 5,580만 달러 |
본 조사에서는 향후 수년간 전 세계 수의용 POC(Point of Care) 진단 시장의 성장을 견인할 주요 요인 중 하나로, 임상 워크플로우에 AI 및 자동 영상 분석 기술을 통합하는 것을 꼽고 있습니다. 또한, 커넥티드 원격의료 플랫폼의 보급과 클라우드 기반 진단 통합, 나아가 분자진단 검사 분야의 멀티플렉싱 및 분산화 진전 또한 시장에서 상당한 수요를 창출할 것으로 전망됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 제품 유형별
제9장 시장 세분화 : 동물 유형별
제10장 시장 세분화 : 최종사용자별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSMThe global veterinary point-of-care diagnostics market is forecasted to grow by USD 2255.8 mn during 2025-2030, accelerating at a CAGR of 10.9% during the forecast period. The report on the global veterinary point-of-care diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing trend of pet humanization and rising adoption rates in north america and apac, increasing prevalence of zoonotic diseases and need for rapid disease surveillance, technological advancements in molecular diagnostics and instrument miniaturization.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 10.2% |
| CAGR | 10.9% |
| Incremental Value | $2255.8 mn |
Technavio's global veterinary point-of-care diagnostics market is segmented as below:
By Product Type
- Clinical biochemistry
- Immunodiagnostics
- Hematology
- Molecular diagnostics
- Others
By Animal Type
- Companion animals
- Livestock animals
By End-User
- Veterinary clinics
- Veterinary hospitals and academic institute
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Taiwan
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- UAE
- Turkey
- Rest of World (ROW)
This study identifies the integration of ai and automated image analysis in clinical workflows as one of the prime reasons driving the global veterinary point-of-care diagnostics market growth during the next few years. Also, proliferation of connected telehealth platforms and cloud-based diagnostic integration and advancements in multiplexing and decentralization of molecular diagnostic testing will lead to sizable demand in the market.
The report on the global veterinary point-of-care diagnostics market covers the following areas:
- Global veterinary point-of-care diagnostics market sizing
- Global veterinary point-of-care diagnostics market forecast
- Global veterinary point-of-care diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global veterinary point-of-care diagnostics market vendors that include Abbott Laboratories, Antech Diagnostics Inc., Boule Diagnostics AB, Chengdu Seamaty Co. Ltd., Eurolyser Diagnostics GmbH, FUJIFILM Holdings Corp., Genrui Biotech Inc., HORIBA Ltd., IDEXX Laboratories Inc., Mindray Animal Medical, Nova Biomedical Corp., QIAGEN N.V., Randox Laboratories Ltd., Siemens Healthineers AG, Skyla Corp., Thermo Fisher Scientific Inc., Tianjin MNCHIP Co Ltd., URIT Medical Electronic Co Ltd., Werfenlife SA, Zoetis Inc.. Also, the global veterinary point-of-care diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by Animal Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Veterinary Point-Of-Care Diagnostics Market 2020 - 2024
- Historic Market Size - Data Table on Global Veterinary Point-Of-Care Diagnostics Market 2020 - 2024 ($ million)
- 5.2 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
- 5.3 Animal Type segment analysis 2020 - 2024
- Historic Market Size - Animal Type Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Veterinary Point-of-Care Diagnostics Market
- 6.2 Impact of geopolitical conflicts on Global Veterinary Point-of-Care Diagnostics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product Type
- 8.1 Market segments
- 8.2 Comparison by Product Type
- 8.3 Clinical biochemistry - Market size and forecast 2025-2030
- 8.4 Immunodiagnostics - Market size and forecast 2025-2030
- 8.5 Hematology - Market size and forecast 2025-2030
- 8.6 Molecular diagnostics - Market size and forecast 2025-2030
- 8.7 Others - Market size and forecast 2025-2030
- 8.8 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
9 Market Segmentation by Animal Type
- 9.1 Market segments
- 9.2 Comparison by Animal Type
- 9.3 Companion animals - Market size and forecast 2025-2030
- 9.4 Livestock animals - Market size and forecast 2025-2030
- 9.5 Market opportunity by Animal Type
- Market opportunity by Animal Type ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Veterinary clinics - Market size and forecast 2025-2030
- 10.4 Veterinary hospitals and academic institute - Market size and forecast 2025-2030
- 10.5 Others - Market size and forecast 2025-2030
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 APAC - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Australia - Market size and forecast 2025-2030
- 12.5.6 Taiwan - Market size and forecast 2025-2030
- 12.6 South America - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Argentina - Market size and forecast 2025-2030
- 12.6.3 Colombia - Market size and forecast 2025-2030
- 12.7 Middle East and Africa - Market size and forecast 2025-2030
- 12.7.1 South Africa - Market size and forecast 2025-2030
- 12.7.2 UAE - Market size and forecast 2025-2030
- 12.7.3 Saudi Arabia - Market size and forecast 2025-2030
- 12.7.4 Turkey - Market size and forecast 2025-2030
- 12.7.5 Israel - Market size and forecast 2025-2030
- 12.8 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Growing trend of pet humanization and rising adoption rates in North America and APAC
- Increasing prevalence of zoonotic diseases and need for rapid disease surveillance
- Technological advancements in molecular diagnostics and instrument miniaturization
- 13.2 Market challenges
- High financial barriers and capital expenditure requirements for advanced diagnostic systems
- Shortage of specialized technical personnel and complexity of data interpretation
- Fragmented regulatory frameworks and absence of harmonized quality standards
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of AI and automated image analysis in clinical workflows
- Proliferation of connected telehealth platforms and cloud-based diagnostic integration
- Advancements in multiplexing and decentralization of molecular diagnostic testing
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Antech Diagnostics Inc.
- Antech Diagnostics Inc. - Overview
- Antech Diagnostics Inc. - Product / Service
- Antech Diagnostics Inc. - Key offerings
- SWOT
- 15.6 Boule Diagnostics AB
- Boule Diagnostics AB - Overview
- Boule Diagnostics AB - Product / Service
- Boule Diagnostics AB - Key offerings
- SWOT
- 15.7 FUJIFILM Holdings Corp.
- FUJIFILM Holdings Corp. - Overview
- FUJIFILM Holdings Corp. - Business segments
- FUJIFILM Holdings Corp. - Key news
- FUJIFILM Holdings Corp. - Key offerings
- FUJIFILM Holdings Corp. - Segment focus
- SWOT
- 15.8 HORIBA Ltd.
- HORIBA Ltd. - Overview
- HORIBA Ltd. - Business segments
- HORIBA Ltd. - Key offerings
- HORIBA Ltd. - Segment focus
- SWOT
- 15.9 IDEXX Laboratories Inc.
- IDEXX Laboratories Inc. - Overview
- IDEXX Laboratories Inc. - Business segments
- IDEXX Laboratories Inc. - Key offerings
- IDEXX Laboratories Inc. - Segment focus
- SWOT
- 15.10 Mindray Animal Medical
- Mindray Animal Medical - Overview
- Mindray Animal Medical - Product / Service
- Mindray Animal Medical - Key offerings
- SWOT
- 15.11 Nova Biomedical Corp.
- Nova Biomedical Corp. - Overview
- Nova Biomedical Corp. - Product / Service
- Nova Biomedical Corp. - Key offerings
- SWOT
- 15.12 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.13 Randox Laboratories Ltd.
- Randox Laboratories Ltd. - Overview
- Randox Laboratories Ltd. - Product / Service
- Randox Laboratories Ltd. - Key offerings
- SWOT
- 15.14 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.15 Skyla Corp.
- Skyla Corp. - Overview
- Skyla Corp. - Product / Service
- Skyla Corp. - Key offerings
- SWOT
- 15.16 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.17 Werfenlife SA
- Werfenlife SA - Overview
- Werfenlife SA - Product / Service
- Werfenlife SA - Key offerings
- SWOT
- 15.18 Zoetis Inc.
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
